Skip to main content
Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma

Fig. 4

CM272 synergizes with antitumor drugs in the inhibition of PDAC cells growth. A Combination study of the growth inhibitory effects of CM272 and gemcitabine (GEM), cisplatin (CDDP) and FOLFIRINOX (FOLFX) in MIA PaCa-2 cells. B Combination study of the growth inhibitory effects of CM272 and lovastatin (LVT) in MIA PaCa-2 cells. *p < 0.05; **p < 0.01; ***p < 0.001

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us